482 related articles for article (PubMed ID: 11129291)
1. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
Dolnikov A; Millington M; Sun LQ; Symonds G
Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cell cycle entry and G1 progression by CSF-1.
Roussel MF
Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells.
Mitchell KO; El-Deiry WS
Cell Growth Differ; 1999 Apr; 10(4):223-30. PubMed ID: 10319992
[TBL] [Abstract][Full Text] [Related]
4. Ribozyme-mediated suppression of v-myc expression abrogates apoptosis in transformed monocytes.
Dolnikov A; King A; Luxford C; Symonds G; Sun LQ
Cancer Gene Ther; 1996; 3(5):289-95. PubMed ID: 8894247
[TBL] [Abstract][Full Text] [Related]
5. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
6. Tumor progression following transformation of murine monocytes by v-myc: acquisition of immortalization and tumorigenicity.
Stapleton P; Takayama Y; Hartshorn A; Kalaizis A; Rowe PB; Symonds G
Oncogene; 1991 May; 6(5):807-17. PubMed ID: 1711191
[TBL] [Abstract][Full Text] [Related]
7. Defects in p21WAF1/CIP1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells.
Blagosklonny MV; Prabhu NS; El-Deiry WS
Cancer Res; 1997 Jan; 57(2):320-5. PubMed ID: 9000576
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis in v-myc transformation of myelomonocytic cells and its modulation by CSF-1.
Dolnikov A; Ward RL; Hawkins NJ; Symonds G
Oncogene; 1996 Mar; 12(6):1189-98. PubMed ID: 8649820
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events.
Malliri A; Yeudall WA; Nikolic M; Crouch DH; Parkinson EK; Ozanne B
Cell Growth Differ; 1996 Oct; 7(10):1291-304. PubMed ID: 8891333
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
11. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
Chen HW; Huang HC
Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells.
Kusumoto M; Ogawa T; Mizumoto K; Ueno H; Niiyama H; Sato N; Nakamura M; Tanaka M
Clin Cancer Res; 1999 Aug; 5(8):2140-7. PubMed ID: 10473098
[TBL] [Abstract][Full Text] [Related]
13. p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells.
Kagawa S; Fujiwara T; Hizuta A; Yasuda T; Zhang WW; Roth JA; Tanaka N
Oncogene; 1997 Oct; 15(16):1903-9. PubMed ID: 9365236
[TBL] [Abstract][Full Text] [Related]
14. c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells.
Ceballos E; Delgado MD; Gutierrez P; Richard C; Müller D; Eilers M; Ehinger M; Gullberg U; León J
Oncogene; 2000 Apr; 19(18):2194-204. PubMed ID: 10822369
[TBL] [Abstract][Full Text] [Related]
15. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
[TBL] [Abstract][Full Text] [Related]
16. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
Li H; Wu X
Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
[TBL] [Abstract][Full Text] [Related]
18. Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential.
Symonds G; Hartshorn A; Kennewell A; O'Mara MA; Bruskin A; Bishop JM
Oncogene; 1989 Mar; 4(3):285-94. PubMed ID: 2649846
[TBL] [Abstract][Full Text] [Related]
19. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
20. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
